Search for: "Sanofi US Corporation" Results 41 - 60 of 103
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Oct 2016, 2:59 pm by Michael Grossman
This exact debate happens all the time behind closed boardroom doors in corporate America, and far too often profit wins over pathos. [read post]
20 Aug 2010, 12:56 pm by Stephen Albainy-Jenei
  You can get the discount by registering using code 10386XZ299. [read post]
25 Aug 2017, 7:02 am by Fraud Fighters
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]
25 Aug 2017, 7:02 am by Fraud Fighters
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]
28 Nov 2019, 12:57 pm
The case related to GSK’s European patent EP 1965823, which was opposed by Sanofi, Novo Nordisk, Generics Ltd and Eli Lilly. [read post]
10 Jul 2015, 11:46 am by Greene LLP
Those companies were later narrowed down to just four, AstraZeneca, Cephalon, Biogen and Genzyme Corporation. [read post]
15 Oct 2010, 7:49 am by Keith Lee
It’s just how Sanofi-aventis, Proctor and Gamble and Citibank stay competitive!! [read post]
15 Oct 2008, 3:02 pm
In turn, consumers can no longer use the state protections when harmed by negligence or misconduct, giving total immunity to corporations instead.AAJ has tracked how the administration's first attempts to preempt states rights utilized friend-of-the-court briefs on behalf of corporations in civil justice cases. [read post]
7 Dec 2023, 11:17 am by Seeger Weiss
This appointment positions Buchanan at the forefront of a critical legal battle against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi – who control nearly the entire U.S. insulin market – as well as the nation’s three largest pharmacy benefit managers (PBMs), CVS Caremark, Express Scripts, and OptumRx, over allegations these companies used unlawful, unfair, and deceptive practices to aggressively hike the cost of insulin and other diabetes medications.… [read post]
27 Mar 2019, 11:33 am
Further comment was provided by Katfriend and Louboutin litigation expert Carina Gommers.PatentGuestKat Frantzeska Papadopoulou discusses the boundaries for Supplementary Protection Certificates (SPC) following the Swiss Tribunal decision between Genzyme Corporation (holder of supplementary protection certificate No C00716606/01), and its  licensee, Sanofi-Aventis (holder of the authorizations for the products Renagel and Renvela)OtherGuestKat Ieva… [read post]
9 Apr 2009, 9:27 am
(IP Frontline)   US Patents Percentage of patents that were initially rejected (Patently-O) Design patents: Sailing through the PTO (Patently-O) Patents and the auto industry bailout (Patently-O) Tips for assisting the judge and jury in patent cases (IP Watchdog) US patent counts, Q1 2009 (Patent Librarian's Notebook) What good are patent method claims? [read post]
30 Jan 2020, 5:29 am by Brenda Fulmer
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
30 Jan 2020, 5:29 am by Brenda Fulmer
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
30 Nov 2009, 12:00 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
27 Jan 2011, 9:34 am by Stephen Kohn
 The Cowan firm represents numerous corporations which oppose the FCA, including pharmaceutical companies like Eli Lilly, Merck, and SANOFI-Aventis as well as financial groups like Morgan Stanley and Citigroup. [read post]
16 Jan 2009, 7:00 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
17 Jan 2008, 10:00 pm
: (IP Dragon),China acts to boost patents on publicly funded research: (Intellectual Property Watch),Fighting local protectionism: (China Hearsay),Proposed changes to trade mark law: (International Law Office)DenmarkParallel import not in violation of trade mark rights: (International Law Office),World first record label using creative commons license is Danish: (Innovationpartners)EuropeCroatia and Norway ratify European Patent Convention:… [read post]
14 Jul 2011, 12:56 pm by Frank Pasquale
Ketek was developed in the 1990s by Aventis Pharmaceuticals, now Sanofi-Aventis. [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous… [read post]